AIThe Next Webabout 1 hour ago
Huawei expands AI pharma partnerships with Chinese drugmakers
1 min read
Huawei plans more AI pharma partnerships, mainly with Chinese drugmakers, per healthcare unit president William Zhang. The company sells compound screening tools with Ascend and Kunpeng chips. A May deal with Guangzhou Pharmaceutical Holdings and StoneWise marked the first production validation of domestically developed AI drug models on Huawei silicon.
Level
Hype check
Tap to vote and see what everyone thinks.
In this storyHuawei
